Global & Public Health (all articles)
What can we expect from first-generation COVID-19 vaccines?
22 Sep, 2020 | 10:02h | UTCWhat can we expect from first-generation COVID-19 vaccines? – The Lancet
Commentary on Twitter
We need to calibrate our expectations for the 1st generation of #SARSCoV2 vaccines https://t.co/QTJbyOd9xQ @TheLancet by @gmleunghku and Malik Peiris @hkumed Pe-covid normalcy is not near. pic.twitter.com/Y15TqfoRlf
— Eric Topol (@EricTopol) September 21, 2020
Interesting conversation: Lockdowns, COVID mortality, & when science & politics collide (w/Dr. Eran Bendavid)
22 Sep, 2020 | 09:49h | UTCLockdowns, COVID Mortality, & When Science & Politics Collide (w/Dr. Eran Bendavid) (via @ZDoggMD)
Ensuring adequate palliative and hospice care during COVID-19 surges
22 Sep, 2020 | 09:57h | UTCEnsuring Adequate Palliative and Hospice Care During COVID-19 Surges – JAMA
Commentary on Twitter
An ethical approach to #pandemic surge planning requires providing for patients seeking symptom relief & comfort at the end of life. Not to do so undermines patient, family trust, emotional health, and core values of society https://t.co/P0LeYuZwzt @MatthewWynia @CUPallCare
— JAMA (@JAMA_current) September 22, 2020
‘Landmark moment’: 156 countries agree to Covid vaccine allocation deal
22 Sep, 2020 | 09:45h | UTC‘Landmark moment’: 156 countries agree to Covid vaccine allocation deal – The Guardian
WHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await
22 Sep, 2020 | 09:47h | UTCWHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await – Science
How bad has the pandemic been for childhood vaccinations?
22 Sep, 2020 | 09:41h | UTCHow Bad Has The Pandemic Been For Childhood Vaccinations? – NPR
Perspective: After Coronavirus Disease 2019
22 Sep, 2020 | 09:38h | UTCAfter Coronavirus Disease 2019 – Clinical Infectious Diseases
Commentary on Twitter
Great commentary on "After #COVID19" from epi/ID legend Dr. Richard Wenzel; outlines what an ideal pandemic response would look like and looks ahead to the inevitable next pandemic.
[I did have to look up "ineluctable"]@VCUHealth https://t.co/W4cOxYDjL1
— Mike Stevens (@Dr_Mike_Stevens) September 17, 2020
To find a vaccine for COVID-19, will we have to deliberately infect people?
22 Sep, 2020 | 09:40h | UTCTo find a vaccine for COVID-19, will we have to deliberately infect people? – National Geographic
Guideline: Management of dyslipidemia for cardiovascular disease risk reduction
22 Sep, 2020 | 09:33h | UTCSummary: VA/DoD Guidelines on Dyslipidemia Recommend Against Frequent LDL Testing – NEJM Journal Watch
Commentary on Twitter
https://twitter.com/ATallantMD/status/1308199038513278978
Increased patient safety-related incidents following the transition into daylight savings time
22 Sep, 2020 | 09:22h | UTC
Commentary on Twitter
As if it wasn’t bad enough we have to change the few remaining analog clocks twice a year due to daylight savings time (DST); DST change leads to about 19% more patient safety incidents in the following week attributed to human error. #PatientSafety https://t.co/YBFtgjgsLT
— David (@ResearchMohr) September 15, 2020
[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials
20 Sep, 2020 | 21:42h | UTC
Commentary on Twitter
This meta-analysis of 7,913 patients from 26 RCTs (16 unpublished) found no mortality benefit to #hydroxychloroquine or chloroquine in COVID19
Combined summary OR for all-cause mortality for HCQ 1.08, 95%CI 0.99-1.18
Confirms HCQ does not help, may harmhttps://t.co/4o9bXkOo5Q pic.twitter.com/QG1XMzN0da
— Ilan Schwartz is on🦋 (@GermHunterMD) September 19, 2020
Decreased influenza activity during the COVID-19 pandemic
20 Sep, 2020 | 21:39h | UTCCommentary: COVID-19 prevention might translate into – MedicalXpress
Transmission of SARS-CoV-2 during long flights
20 Sep, 2020 | 21:36h | UTCRelated Study: In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 – CDC Emerging Infectious Diseases
Commentary: Coronavirus can spread on airline flights, two studies show – CNN
Systematic Review: Coronavirus infection in neonates
20 Sep, 2020 | 21:34h | UTCCoronavirus infection in neonates: a systematic review – ADC Fetal & Neonatal
Commentary on Twitter
#SARSCoV2 #review of 26 studies with 44 infected newborns across globe
1. Most aysmptomatic/mild symptoms
2.Most required no RS support
3. Good prognosis-0 deaths
4. 1 in 3 admitted from home
5. Median diagnosis D5; stay 10 days@EBNEO #neoEBM https://t.co/Q0GjmgUg2Y
— Abdul Razak (@DrAbdulRazak_MD) September 19, 2020
A history of herd immunity
20 Sep, 2020 | 21:32h | UTCA history of herd immunity – The Lancet
Uruguay is winning against Covid-19. This is how
20 Sep, 2020 | 21:27h | UTCUruguay is winning against covid-19. This is how – The BMJ
Commentary on Twitter
Latin America continues to suffer some of the worst tolls of covid-19 but somehow Uruguay has a lid on the pandemic. Its relatively small population made controlling transmission easier but never guaranteed success. @LukeStTaylor looks at how it's happened https://t.co/0k4PlTLQyo
— The BMJ (@bmj_latest) September 20, 2020
Most homemade masks are doing a great job, even when we sneeze, study finds
20 Sep, 2020 | 21:22h | UTCMost homemade masks are doing a great job, even when we sneeze, study finds – MedicalXpress
Commentary on Twitter
Two layers of T-shirt cloth block droplets with >94% efficiency vs. medical masks, while being ~2x as breathable. Face coverings made from cotton allow washing and reusing, reducing environmental impact of disposable, non-biodegradable facemasks. 😷👕😷 https://t.co/kyqB4XoZMl
— peter kilmarx (@PeterKilmarx) August 26, 2020
Who gets a COVID vaccine first? Access plans are taking shape
20 Sep, 2020 | 21:24h | UTCWho gets a COVID vaccine first? Access plans are taking shape – Nature
Related: WHO Guidance: Allocation and prioritization of COVID-19 vaccination
Commentary on Twitter
Advisory groups around the world are working out plans for who should get priority access to a #covid19 vaccine: https://t.co/9g67rFJUrT pic.twitter.com/BLhAcKiVCK
— nature (@Nature) September 18, 2020
Hangover from alcohol boom could last long after pandemic ends
20 Sep, 2020 | 21:18h | UTCHangover From Alcohol Boom Could Last Long After Pandemic Ends – NPR
Commentary on Twitter
The alcohol industry has thrived during the #pandemic. But alcohol-related illnesses kill 88,000+ Americans every year—and the skyrocketing sales suggest a worrying reliance on alcohol to ease a stressful situation. https://t.co/8GIbAi9dM7
— Global Health NOW (@ghn_news) September 20, 2020
Perspective: How we survive the winter
20 Sep, 2020 | 21:21h | UTCHow We Survive the Winter – The Atlantic
CDC Guidance: Indicators for dynamic school decision-making
18 Sep, 2020 | 09:45h | UTCIndicators for Dynamic School Decision-Making – Centers for Disease Control and Prevention
Commentary on Twitter
CDC releases new epi indicators and thresholds for risk of introduction and transmission of COVID-19 in schools https://t.co/jGQUV149Wt pic.twitter.com/xNmA7iUbaF
— Caitlin Rivers (@cmyeaton) September 16, 2020
The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion
20 Sep, 2020 | 21:16h | UTC
Commentary on Twitter
Non-communicable diseases & injuries (NCDI) cause more death & disability at every age among the world’s poorest billion than in wealthy countries— new @ncdipoverty Commission provides cost-effective & equitable interventions to address #NCDIPoverty https://t.co/MPunOR7fws pic.twitter.com/IrGj2obZXx
— The Lancet (@TheLancet) September 14, 2020
Transmission of SARS-CoV-2: A review of viral, host, and environmental factors
18 Sep, 2020 | 09:43h | UTC
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
18 Sep, 2020 | 09:34h | UTCClustering and superspreading potential of SARS-CoV-2 infections in Hong Kong – Nature Medicine
Commentary: Superspreaders of SARS-CoV-2 – Virology Blog
Commentaries on Twitter
Cases linked to #superspreading events are estimated to account for 80% of all local transmission of #SARSCoV2 in Hong Kong in a study with implications for public health policies. @bencowling88 @gmleunghku @SCauchemez @DillonCAdam @hkumed #quarantinehttps://t.co/tniPhKNhs5
— Nature Medicine (@NatureMedicine) September 17, 2020
We can learn a lot about superspreader events from this new @NatureMedicine paper https://t.co/ouO7CyGXQE by @DillonCAdam @bencowling88 @gmleunghku @hkumed
The Pareto 80/20 rule applied: 19% of infections were responsible for 80% of transmissions; 69% of cases did not transmit— Eric Topol (@EricTopol) September 17, 2020
Covid-19: Do many people have pre-existing immunity?
18 Sep, 2020 | 09:41h | UTCCovid-19: Do many people have pre-existing immunity? – The BMJ
Commentary on Twitter
It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case? Peter Doshi explores the emerging research on immunological responseshttps://t.co/6LYRjxlWBQ
— The BMJ (@bmj_latest) September 17, 2020